scispace - formally typeset
S

Sébastien Bonnet

Researcher at Laval University

Publications -  195
Citations -  12429

Sébastien Bonnet is an academic researcher from Laval University. The author has contributed to research in topics: Pulmonary hypertension & Medicine. The author has an hindex of 54, co-authored 171 publications receiving 10254 citations. Previous affiliations of Sébastien Bonnet include University of Alberta & French Institute of Health and Medical Research.

Papers
More filters
Journal ArticleDOI

Apolipoprotein A-I Mimetic Peptide 4F Rescues Pulmonary Hypertension by Inducing MicroRNA-193-3p

TL;DR: These studies establish the importance of microRNAs as downstream effectors of an apolipoprotein A-I mimetic peptide in the rescue of pulmonary arterial hypertension and suggest that treatment with Apolipop Protein A- I mimetic Peptide or miR193 may have therapeutic value.
Journal ArticleDOI

HDAC6: A Novel Histone Deacetylase Implicated in Pulmonary Arterial Hypertension

TL;DR: For the first time, pharmacological inhibition of HDAC6 improved established PAH in two experimental models and can be safely given in combination with currently approved PAH therapies.
Journal ArticleDOI

Translational Advances in the Field of Pulmonary Hypertension.Translating MicroRNA Biology in Pulmonary Hypertension. It Will Take More Than “miR” Words

TL;DR: Translating MicroRNA Biology in Pulmonary Hypertension It will take more than “miR” Words to be translated into English, and the translated words will need to be modified to reflect the language barrier.
Journal ArticleDOI

RAGE-Dependent Activation of the Oncoprotein Pim1 Plays a Critical Role in Systemic Vascular Remodeling Processes

TL;DR: In vivo, RAGE inhibition decreases STAT3/Pim1/NFAT activation, reversing vascular remodeling in the rat carotid artery-injured model and Molecules aimed to inhibit RAGE could be of a great therapeutic interest for the treatment of VRD.